March 28, 2006

Disasterous Drug Trial_FDA New Rules Ensure More Disasters to Follow

The FDA has quietly adopted a radical policy to boost the biotech-pharmaceutical industry. The drug, TGN1412, a

Read More
Disasterous Drug Trial_FDA New Rules Ensure More Disasters to Follow

March 3, 2006

FDA Approval process under fire–PML: Lethal side-effect–Tysabri: Multiple Sclerosis Drug

Biogen and Elan, the manufacturers of the drug, Tysabri, refused to release her medical records and imaging

Read More
FDA Approval process under fire–PML: Lethal side-effect–Tysabri: Multiple Sclerosis Drug